• Skip to main content
  • Skip to primary sidebar
  • Home
  • News
  • Education
  • Events
  • Interviews
    • Career spotlight
  • Opinion
    • Professional Dilemmas
    • Patient perspective
  • PIPcast
  • Jobs
  • Business Directory

Pharmacy in Practice

EDX/20/1154
Date of prep: December 2020

Prescribing information and
adverse events reporting

For healthcare professionals only

Three additional benzodiazepines to become class C drugs

9th September 2020 by PIP editor Leave a Comment

 

Crime and Policing Minister Kit Malthouse has announced that three benzodiazepines will be made Class C drugs.

 

Flualprazolam, flunitrazolam and norfludiazepam will be controlled as Class C drugs under the Misuse of Drugs Act 1971 and placed in Schedule 1 to the Misuse of Drugs Regulations 2001, following a recommendation from the Advisory Council on the Misuse of Drugs (ACMD).

 

As of March 2020, there had been 12 flualprazolam-associated deaths in the UK.

 

Crime and Policing Minister Kit Malthouse said:

 

“Illegal drugs ruin lives and corrode the foundations of our society.

 

“It’s clear from the expert advice that we have received that these drugs can cause serious harm, which is why we are taking this action.”

 

Loader Loading...
EAD Logo Taking too long?

Reload Reload document
| Open Open in new tab

 

This article is being shared under the Open Government Copyright licence.

 

 

Related

Next article  Pledge to vaccinate 400k Scots a week by end of February

Filed Under: News Tagged With: illegal drugs

Register for our upcoming webinar and live Q&A

About PIP editor

Pharmacy in Practice is a UK pharmacy publication with its roots in Scotland.

Reader Interactions

Begin the discussion right here Cancel reply

Primary Sidebar

Categories

PIP business directory

Letters to the editor

Letters to the editor

I failed by one mark and now can’t register as a pharmacist

Why is a decision on the pre-reg exam problem taking so long?

Why I removed OTC codeine from public view in my pharmacy

I have seen people slide into addiction after taking OTC opiates

More letters to the editor here...

Blogs

💊 PIP live pharmacy blog

Winter stresses must not ‘destabilise’ general practice

What is it like to depend on medicine to treat endometriosis?

Opinion

Why is pharmacy not integral to government mass vaccination plans?

Pharmacy Covid-19 vaccination involvement is a ‘no-brainer’

The great patient medication returns debacle

CPD Challenges

💊 CPD Challenge: How well do you understand pulmonary embolisms?

💊 CPD Challenge: Prescribing and dispensing clozapine

💊 CPD Challenge: Oral anticoagulants – Dabigatran

More CPD challenges here...

© 2021 · About Pharmacy In Practice · Site mantained by Mike

This site is for healthcare professionals, please confirm you are a healthcare professional to continue.

YES

Pharmacy In Practice uses cookies, by continuing to use this site we will assume you are ok with that Find out more.